Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for STRATA Skin Sciences (SSKN) over the last 14 years, with Q3 2025 value amounting to $30.7 million.

  • STRATA Skin Sciences' Liabilities and Shareholders Equity fell 2200.44% to $30.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.2 million, marking a year-over-year decrease of 1958.35%. This contributed to the annual value of $34.9 million for FY2024, which is 1686.98% down from last year.
  • STRATA Skin Sciences' Liabilities and Shareholders Equity amounted to $30.7 million in Q3 2025, which was down 2200.44% from $29.5 million recorded in Q2 2025.
  • STRATA Skin Sciences' 5-year Liabilities and Shareholders Equity high stood at $55.2 million for Q2 2023, and its period low was $29.5 million during Q2 2025.
  • For the 5-year period, STRATA Skin Sciences' Liabilities and Shareholders Equity averaged around $44.1 million, with its median value being $45.9 million (2021).
  • As far as peak fluctuations go, STRATA Skin Sciences' Liabilities and Shareholders Equity skyrocketed by 2013.56% in 2022, and later crashed by 2978.95% in 2024.
  • STRATA Skin Sciences' Liabilities and Shareholders Equity (Quarter) stood at $46.6 million in 2021, then rose by 12.19% to $52.3 million in 2022, then dropped by 19.62% to $42.0 million in 2023, then fell by 16.87% to $34.9 million in 2024, then fell by 12.06% to $30.7 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $30.7 million for Q3 2025, versus $29.5 million for Q2 2025 and $33.0 million for Q1 2025.